1950 studies found for:    Open Studies | mri
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | mri
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain Tumors
Conditions: Metastatic Malignant Neoplasm in the Brain;   Primary Brain Neoplasm
Interventions: Procedure: 3 Tesla Magnetic Resonance Imaging;   Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging;   Drug: Ferumoxytol;   Drug: Gadolinium;   Procedure: High Field Strength Magnetic Resonance Imaging;   Procedure: Susceptibility Weighted Imaging
2 Recruiting 3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer
Condition: Prostate Cancer
Interventions: Procedure: 3-Tesla magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: magnetic resonance spectroscopic imaging
3 Recruiting Using MRI-Guided Laser Heat Ablation to Induce Disruption of the Peritumoral Blood Brain Barrier to Enhance Delivery and Efficacy of Treatment of Pediatric Brain Tumors
Conditions: Glioma;   Pilocytic Astrocytoma;   Anaplastic Astrocytoma;   Glioblastoma;   Mixed Oligoastrocytoma;   Mixed Glioma;   Oligodendroglioma;   Optic Glioma;   Astrocytoma
Interventions: Procedure: MRI-guided laser ablation;   Drug: Doxorubicin;   Drug: Etoposide;   Device: Dynamic contrast-enhanced (DCE) MRI;   Device: Dynamic susceptibility contrast (DSC) MRI
4 Recruiting NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Prostate Carcinoma
Interventions: Procedure: Contrast-enhanced Magnetic Resonance Imaging;   Radiation: Fludeoxyglucose F-18;   Radiation: Fluorine F 18 Sodium Fluoride;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
5 Not yet recruiting Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer
Conditions: Stage IIB Esophageal Cancer;   Stage IIIA Esophageal Cancer;   Stage IIIB Esophageal Cancer;   Stage IIIC Esophageal Cancer
Interventions: Drug: Ferumoxytol;   Procedure: Magnetic Resonance Imaging;   Device: Magnetic Resonance Imaging;   Device: PET/CT
6 Recruiting Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer
Conditions: Health Status Unknown;   Prostate Carcinoma
Interventions: Procedure: 3 Tesla Magnetic Resonance Imaging;   Radiation: Gadodiamide;   Procedure: Multiparametric Magnetic Resonance Imaging;   Procedure: Transrectal Biopsy;   Procedure: Ultrasound-Guided Prostate Biopsy
7 Recruiting FAST MRI Study in Breast Cancer Survivors
Condition: Breast Cancer
Intervention: Other: FAST MRI and mammography screening
8 Recruiting Safety Evaluation of Intra-Operative MRI-Based Guidance for Laser Ablation of Epidural Metastasis
Condition: Spinal Tumor
Interventions: Procedure: Magnetic Resonance Imaging (MRI);   Behavioral: Questionnaires
9 Recruiting MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Undifferentiated Carcinoma;   Recurrent Cervical Carcinoma;   Stage IB2 Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging;   Radiation: Fludeoxyglucose F-18;   Procedure: Magnetic Resonance Spectroscopic Imaging;   Procedure: Positron Emission Tomography
10 Recruiting Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer
Condition: Recurrent Prostate Cancer
Interventions: Procedure: computed tomography;   Procedure: bone scan;   Procedure: 3-Tesla magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Radiation: fluorine F 18 sodium fluoride;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis
11 Recruiting Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
Condition: Adult Brain Glioblastoma
Interventions: Procedure: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging;   Drug: Ferumoxytol;   Drug: Gadoteridol;   Procedure: Magnetic Resonance Imaging
12 Not yet recruiting Perfusion MRI in Reversible Cerebral Vasoconstriction Syndrome
Condition: Reversible Cerebral Vasoconstriction Syndrome
Interventions: Device: MRI brain;   Device: ASL-MRI brain;   Device: MRA brain
13 Recruiting 68Ga-PSMA PET/MRI in Finding Tumors in Patients With Intermediate or High-Risk Prostate Cancer Undergoing Surgery
Conditions: Stage II Prostate Adenocarcinoma;   Stage III Prostate Adenocarcinoma
Interventions: Drug: gallium Ga 68-PSMA;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
14 Recruiting Cardiac MRI in Measuring the Impact of Anti-androgen Treatment on Cardiac Function in Patients With Prostate Cancer
Conditions: Cardiovascular Injury;   Prostate Carcinoma
Interventions: Procedure: Magnetic Resonance Imaging;   Behavioral: Exercise Intervention;   Radiation: Gadopentetate Dimeglumine;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Spectroscopy;   Other: Laboratory Biomarker Analysis
15 Recruiting Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery
Condition: Glioblastoma
Interventions: Procedure: Diffusion Weighted Imaging;   Drug: Gadolinium;   Other: Laboratory Biomarker Analysis;   Procedure: Magnetic Resonance Imaging;   Procedure: Perfusion Magnetic Resonance Imaging
16 Recruiting Extramedullary Leukemia (EML) in Newly Diagnosed Acute Myeloid Leukemia (AML) is Underreported
Condition: Leukemia
Interventions: Drug: 18F-FDG;   Procedure: Whole Body Magnetic Resonance Imaging (MRI);   Drug: Gadolinium;   Procedure: Positron Emission Tomography/ Computed Tomography (PET/CT)
17 Recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
18 Recruiting Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Conditions: Hepatocellular Carcinoma;   HCC
Intervention: Device: Magnetic Resonance Imaging
19 Recruiting 68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer
Condition: Prostate Adenocarcinoma
Interventions: Radiation: Gallium Ga 68-labeled GRPR Antagonist BAY86-7548;   Procedure: Magnetic Resonance Imaging;   Procedure: Positron Emission Tomography
20 Recruiting Predicting RadIotherapy ReSponse of Rectal Cancer With MRI and PET
Condition: Rectal Neoplasms
Interventions: Other: Early MRI and PET/CT - 2 weeks after commencing chemo/RT;   Other: Late MRI and PET/CT 6 weeks post chemo/RT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years